PROCLINICAL

The computed 12-month bankruptcy probability of PROCLINICAL is 1.9% (moderate). The 2025 annual accounts show equity of €300,411 and a net result of €89,839. Equity is growing by about 68% per year across the filed financial years. Its solvency ranks better than 53% of 374 sector peers (NACE 78, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.